Multidrug-resistant organisms in patients from Ukraine in the Netherlands, March to August 2022-Reference-Cited by-同舟云学术

Multidrug-resistant organisms in patients from Ukraine in the Netherlands, March to August 2022

Published:2022-12-15 Issue:50 Volume:27 Page:
ISSN:1560-7917
Container-title:Eurosurveillance
language:en
Short-container-title:

Author:

Zwittink Romy D¹^ORCID,Wielders Cornelia CH¹^ORCID,Notermans Daan W¹^ORCID,Verkaik Nelianne J²^ORCID,Schoffelen Annelot F¹^ORCID,Witteveen Sandra¹^ORCID,Ganesh Varisha A¹,de Haan Angela¹^ORCID,Bos Jeroen¹,Bakker Jacinta¹^ORCID,Schneeberger-van der Linden Caroline¹,Kuijper Ed J¹^ORCID,de Greeff Sabine C¹^ORCID,Hendrickx Antoni PA¹^ORCID,

Affiliation:

1. Centre for Infectious Disease Control (CIb), National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands

2. SWAB Working Group Surveillance of Antibiotic Resistance, Department of Medical Microbiology and Infectious Diseases, Erasmus University Medical Center, Rotterdam, the Netherlands

Abstract

Since March 2022, there has been an emergence of multidrug-resistant organisms (MDRO) in the Netherlands in patients originating from Ukraine (58 patients, 75 isolates). For about half of these patients, recent hospitalisation in Ukraine was reported. Genomic surveillance revealed that the majority of the MDRO represent globally spread epidemic lineages and that 60% contain New Delhi metallo-β-lactamase (NDM) genes. Professionals should be aware of an increase in such MDRO associated with migration and medical evacuation of people from Ukraine.

Publisher

European Centre for Disease Control and Prevention (ECDC)

Subject

Virology,Public Health, Environmental and Occupational Health,Epidemiology

Reference16 articles.

1. de Greeff SC, Kolwijck E, Schoffelen AF, Verduin CM. NethMap 2022. Consumption of antimicrobial agents and antimicrobial resistance among medically important bacteria in the Netherlands in 2021 / MARAN 2022. Monitoring of Antimicrobial Resistance and Antibiotic Usage in Animals in the Netherlands in 2021. Bilthoven: Rijksinstituut voor Volksgezondheid en Milieu; 2022. Available from: https://www.rivm.nl/publicaties/nethmap-2022-consumption-of-antimicrobial-agents

2. Molecular characteristics of carbapenemase-producing Enterobacterales in the Netherlands; results of the 2014-2018 national laboratory surveillance.;van der Zwaluw;Clin Microbiol Infect,2020

3. World Health Organization Regional Office for Europe (WHO/Europe)/European Centre for Disease Prevention and Control (ECDC). Antimicrobial resistance surveillance in Europe 2022 – 2020 data. Copenhagen: WHO/Europe; 2022. Available from: https://apps.who.int/iris/handle/10665/351141. License: CC BY-NC-SA 3.0 IGO

4. Epidemiology of carbapenem-resistant and carbapenemase-producing Enterobacterales in the Netherlands 2017-2019.;Wielders;Antimicrob Resist Infect Control,2022

5. European Commission (EC). Ukraine: 1,000 Ukrainian patients transferred to European hospitals. Press release. Brussels: EC; 2022. Available from: https://ec.europa.eu/commission/presscorner/detail/en/IP_22_4882

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. First detection in Spain of NDM-1-producing Pseudomonas aeruginosa in two patients transferred from Ukraine to a university hospital;Journal of Global Antimicrobial Resistance;2024-03

2. Characterization of blaOXA-48-carrying plasmids and small non-AMR-coding plasmids collected from Ukrainian patients;Infection;2023-11-29

3. The contribution of human conflict to the development of antimicrobial resistance;Communications Medicine;2023-10-25

4. Genotypic characterisation of carbapenemase-producing organisms obtained in Denmark from patients associated with the war in Ukraine;Journal of Global Antimicrobial Resistance;2023-09

5. Six Extensively Drug-Resistant Bacteria in an Injured Soldier, Ukraine;Emerging Infectious Diseases;2023-08